Feedback / Questions
Oral Pyridorin (pyridoxamine) - NephroGenex
NephroGenex: Corporate Presentation
(Nephrogenex)
-
May 9, 2015 -
Anticipated interim analysis after occurrence of 80 events in P3 PIONEER trial in diabetic nephropathy in mid-2016
Anticipated DSMB
•
Diabetic Nephropathy • Renal Disease
http://investors.nephrogenex.com/sites/nephrogenex.investorhq.businesswire.com/files/doc_library/file/NRX_Presentation_to_Load_to_Website.pdf
May 9, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.